3.8 Gene Tools, Mutagens and Cancer

In a gene knockout, researchers disrupt or disable a selected gene and compare the resulting organism or cells with a suitable control. If the knockout has a changed phenotype, the missing gene is implicated in the affected process. The inference is rarely one-to-one: genes can have several functions, pathways can compensate, and genetic background or environment can modify the phenotype. Replication, randomization and rescue experiments strengthen conclusions.

Highly conserved DNA or amino-acid sequences have changed little across evolutionary lineages. Conservation suggests that many alternatives were removed by selection because the sequence performs an important function. Knockout or targeted mutation can test that inference. Conversely, no phenotype under one laboratory condition does not prove no function; the relevant stress, developmental stage or interaction may be absent.

CRISPR systems originated as part of prokaryotic defence against viruses. Stored fragments related to past invaders help guide Cas nucleases to complementary nucleic acid. In engineered CRISPR–Cas9 editing, a guide RNA directs Cas9 to a matching DNA sequence adjacent to a required recognition motif. Cas9 cuts the DNA, and the cell's repair machinery produces the final edit.

Error-prone end joining can introduce small insertions or deletions that disrupt a reading frame and knock out a gene. If a repair template is supplied, homology-directed repair can sometimes install a specific sequence change. Editing efficiency, off-target cutting, mosaicism and delivery all matter. The guide provides targeting specificity, but it does not by itself write the desired replacement sequence.

Editing somatic cells affects the treated individual, whereas editing an embryo or germ-line lineage could pass a change to future people who cannot consent. A proposed use must be judged by expected benefit, alternatives, uncertainty, equitable access and the possibility of unintended edits—not merely by whether a cut can be made. The same technique can support tightly controlled disease research or ethically unacceptable enhancement, so technical capability does not settle the decision.

Mutagens increase mutation rate. Ultraviolet radiation can produce abnormal bonds between neighboring pyrimidines, ionizing radiation can damage bases and break DNA strands, and chemical mutagens can modify bases or interfere with replication. Some viruses contribute genes or regulatory effects that promote uncontrolled division. A carcinogen increases cancer risk; many carcinogens are mutagens, but the terms are not perfectly interchangeable.

Normal tissues balance cell division, differentiation and programmed cell death. Cell-cycle checkpoints delay progression when DNA is damaged. DNA repair may restore integrity, while apoptosis can eliminate a cell whose damage is irreparable. Mutations that activate growth-promoting genes or disable tumour-suppressor, repair or apoptosis pathways give a cell lineage a selective advantage within the tissue.

A tumour is a mass produced by abnormal cell proliferation. A benign tumour remains localized, although its size or hormone production can still cause harm. A malignant tumour invades surrounding tissue. Cells that detach, travel through blood or lymph and establish secondary tumours produce metastasis. Cancer usually requires an accumulation of changes rather than a single mutation, which helps explain why risk rises with age and exposure.

Smoking illustrates evidence built from several levels: population studies reveal a dose-related association with lung cancer, chemical analysis identifies carcinogens, and laboratory studies show DNA damage and biological mechanisms. Correlation alone does not establish causation, but consistency, temporality, dose response, mechanism and reduction in risk after exposure falls make the causal case much stronger.